mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |